Structure‐Based Identification and Synthesis of Benzimidazole Azo–Schiff Base Derivatives as Recommended CK2 and PIM‐1 Inhibitors
Drug Development Research · 2026
DOI: 10.1002/ddr.70336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Huda F Hassan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Bilad Alrafidain University, Diyala, Iraq. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Casein Kinase II, Benzimidazoles, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Casein Kinase‐2 (CK2) and Proviral Integration site for Moloney murine leukemia virus‐1 (PIM‐1) are kinases that are continuously active and work together to promote oncogenesis, thus becoming an important target for anti‐cancer drugs. This research highlights the design, synthesis, and in silico evaluation of a new class of azo–Schiff bases bearing benzimidazole moieties (A1–A7) as potential dual inhibitors of CK2/PIM‐1 targets. The compounds were synthesized using diazotization/azocoupling reaction and Schiff's base condensation reactions, where structural elucidation was accomplished through FT‐IR, 1H NMR, and 13C NMR analyses. The molecular docking process was performed using the GOLD docking program against ATP‐binding sites on CK2 (PDB: 4DTK) and PIM‐1 (PDB: 4KWP), followed by MD simulation for 100 ns using GROMACS software. Through computational screening, molecules A4 and A6 were found to be the most potent dual inhibitors. Compound A6 displayed the greatest affinity to CK2 with a PLP fitness value of 81.33, whereas compound A4 displayed the highest affinity to PIM‐1 with a PLP fitness value of 86.80. The interesting thing is that both compounds revealed very good cross‐reactivity to both enzymes and were superior to other compounds in the series concerning dual‐target PLP fitness. The MD simulation results showed that A4 and A6 exhibit high stability in their interactions with minimal structural fluctuations, attributed to hydrogen bonds formed consistently within the active site regions. In contrast, A7 has been shown to be a PIM‐1 selective inhibitor. The attachment of azo–Schiff base groups to the benzimidazole core results in an interesting structure with a potential for multi‐kinase inhibitory activity. The current study has identified molecules A4 and A6 as potential leads that require further in vitro and in vivo validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, Bilad Alrafidain University, Diyala, Iraq.
- Chemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
- Department of Chemistry, College of Education, University of Samarra, Samarra, Iraq.
- Department of Pharmaceutical Chemistry, College of Pharmacy, The University of Mashreq, Baghdad, Iraq.
- Department of Chemistry, College of Education for Pure Science, University of Diyala, Diyala, Iraq.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt.
ORCID-Profile: Maha Salih Hussein, Mohamed N Goda, Tarek A Yousef, Ahmed A Al-Karmalawy
Zitieren
APA
Hassan, H. F., Eissa, M. E., Hussein, M. S., Al-Qazzan, M. B., Al-Akeedi, M., Goda, M. N., Al-Tameemi, S. J., Abed, H. N., Ibraheem, T. K., Yousef, T. A., & Al-Karmalawy, A. A. (2026). Structure‐Based Identification and Synthesis of Benzimidazole Azo–Schiff Base Derivatives as Recommended CK2 and PIM‐1 Inhibitors. Drug Development Research. https://doi.org/10.1002/ddr.70336
Vancouver
Hassan HF, Eissa ME, Hussein MS, Al-Qazzan MB, Al-Akeedi M, Goda MN, et al. Structure‐Based Identification and Synthesis of Benzimidazole Azo–Schiff Base Derivatives as Recommended CK2 and PIM‐1 Inhibitors. Drug Development Research. 2026. doi:10.1002/ddr.70336
BibTeX
@article{Hassan2026,
author = {Hassan, Huda F and Eissa, Mohamed E and Hussein, Maha Salih and Al-Qazzan, Mohammed Bashar and Al-Akeedi, Mohammed and Goda, Mohamed N and Al-Tameemi, Sadeq Jaafer and Abed, Haithem N and Ibraheem, Tareq K and Yousef, Tarek A and Al-Karmalawy, Ahmed A},
title = {Structure‐Based Identification and Synthesis of Benzimidazole Azo–Schiff Base Derivatives as Recommended CK2 and PIM‐1 Inhibitors},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70336}
}
EUVIMED